Your browser doesn't support javascript.
loading
Angiotensin II receptor blockade with valsartan decreases plasma osteopontin levels in patients with essential hypertension.
Kurata, M; Okura, T; Irita, J; Enomoto, D; Nagao, T; Jotoku, M; Miyoshi, K; Desilva, V R; Higaki, J.
Affiliation
  • Kurata M; Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon City, Ehime, Japan.
J Hum Hypertens ; 25(5): 334-9, 2011 May.
Article in En | MEDLINE | ID: mdl-20664555
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Valine / Angiotensin II Type 1 Receptor Blockers / Osteopontin / Hypertension Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hum Hypertens Journal subject: ANGIOLOGIA Year: 2011 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Valine / Angiotensin II Type 1 Receptor Blockers / Osteopontin / Hypertension Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hum Hypertens Journal subject: ANGIOLOGIA Year: 2011 Document type: Article Affiliation country: Japón Country of publication: Reino Unido